Publications by authors named "Erwin Surmann"

Claim this Profile
P
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects.
Yun Liu, Brian Tomlinson, Jiyuan Guo, Mahnaz Asgharnejad, Lars Bauer, Erwin Surmann

Clin Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
Zhen-Xin Zhang, Chun-Feng Liu, En-Xiang Tao, Ming Shao, Yi-Ming Liu, Erwin Surmann

Parkinsonism Relat Disord· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study" [Park. Relat. Disord. 28 (2016) 49-55].
Zhen-Xin Zhang, Hui-Fang Shang, Xingyue Hu, Shengdi Chen, Zhongxin Zhao, Erwin Surmann

Parkinsonism Relat Disord· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain.
Olivier Rascol, Theresa Zesiewicz, K Ray Chaudhuri, Mahnaz Asgharnejad, Erwin Surmann

J Clin Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
Zhen-Xin Zhang, Hui-Fang Shang, Xingyue Hu, Shengdi Chen, Zhongxin Zhao, Erwin Surmann

Parkinsonism Relat Disord· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
Robert A Hauser, Jaroslaw Slawek, Paolo Barone, Elisabeth Dohin, Erwin Surmann

BMC Neurol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease.
Anthony P Nicholas, Rupam Borgohain, Pedro Chaná, Erwin Surmann, Emily L Thompson

J Parkinsons Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease.
Nir Giladi, Liesbet Ghys, Erwin Surmann, Babak Boroojerdi, Joseph Jankovic

Parkinsonism Relat Disord· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study.
Todd J Swick, Joseph H Friedman, K Ray Chaudhuri, Erwin Surmann, Babak Boroojerdi

Eur Neurol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study.
Jan Kassubek, Kallol Ray Chaudhuri, Theresa Zesiewicz, Erwin Surmann, Babak Boroojerdi

BMC Neurol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.
Nir Giladi, Babak Boroojerdi, Erwin Surmann

J Neural Transm (Vienna)· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.
Peter A LeWitt, Babak Boroojerdi, Erwin Surmann, Werner Poewe,

J Neural Transm (Vienna)· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
K Ray Chaudhuri, Pablo Martinez-Martin, Angelo Antonini, Richard G Brown, Joseph H Friedman, Erwin Surmann

Parkinsonism Relat Disord· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.
Lawrence W Elmer, Erwin Surmann, Babak Boroojerdi, Joseph Jankovic

Parkinsonism Relat Disord· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline.
Liesbet Ghys, Erwin Surmann, John Whitesides, Babak Boroojerdi

Expert Opin Pharmacother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
Claudia Trenkwalder, Bryan Kies, Monika Rudzinska, Jennifer Fine, Janos Nikl, Erwin Surmann

Mov Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis